PortfoliosLab logo

Alkem Laboratories Limited (ALKEM.NS)

Equity · Currency in INR · Last updated May 27, 2023

Company Info

ISININE540L01014
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap₹400.05B
EPS₹85.21
PE Ratio39.27
PEG RatioN/A
Revenue (TTM)₹111.81B
Gross Profit (TTM)₹63.54B
EBITDA (TTM)₹15.63B
Year Range₹2,833.42 - ₹3,625.00
Target Price₹3,324.64

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of ₹10,000 in Alkem Laboratories Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


100.00%120.00%140.00%160.00%180.00%December2023FebruaryMarchAprilMay
159.19%
121.19%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ALKEM.NS

Alkem Laboratories Limited

Return

Alkem Laboratories Limited had a return of 12.20% year-to-date (YTD) and 10.92% in the last 12 months. Over the past 10 years, Alkem Laboratories Limited had an annualized return of 13.97%, outperforming the S&P 500 benchmark which had an annualized return of 11.52%.


PeriodReturnBenchmark
1 month-4.67%1.86%
Year-To-Date12.20%9.87%
6 months9.44%7.85%
1 year10.92%11.03%
5 years (annualized)12.41%12.03%
10 years (annualized)13.97%11.52%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20230.22%6.24%6.96%3.35%
2022-3.72%-0.98%-3.83%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Alkem Laboratories Limited (ALKEM.NS) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ALKEM.NS
Alkem Laboratories Limited
0.82
^GSPC
S&P 500
0.27

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Alkem Laboratories Limited Sharpe ratio is 0.82. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00December2023FebruaryMarchAprilMay
0.82
0.93
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Dividend History

Alkem Laboratories Limited granted a 1.76% dividend yield in the last twelve months. The annual payout for that period amounted to ₹59.00 per share.


PeriodTTM2022202120202019201820172016
Dividend₹59.00₹34.00₹30.00₹25.00₹16.00₹13.00₹9.00₹15.70

Dividend yield

1.76%1.14%0.84%0.88%0.82%0.70%0.43%1.02%

Monthly Dividends

The table displays the monthly dividend distributions for Alkem Laboratories Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023₹0.00₹25.00₹0.00₹0.00
2022₹0.00₹30.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00₹0.00₹0.00₹0.00₹0.00
2021₹0.00₹25.00₹0.00₹0.00₹0.00₹0.00₹0.00₹5.00₹0.00₹0.00₹0.00₹0.00
2020₹0.00₹22.00₹0.00₹0.00₹0.00₹0.00₹0.00₹3.00₹0.00₹0.00₹0.00₹0.00
2019₹0.00₹8.00₹0.00₹0.00₹0.00₹0.00₹0.00₹8.00₹0.00₹0.00₹0.00₹0.00
2018₹0.00₹6.00₹0.00₹0.00₹0.00₹0.00₹0.00₹7.00₹0.00₹0.00₹0.00₹0.00
2017₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹9.00₹0.00₹0.00₹0.00₹0.00
2016₹9.70₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹6.00₹0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2023FebruaryMarchAprilMay
-14.95%
-0.08%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Alkem Laboratories Limited. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Alkem Laboratories Limited is 27.40%, recorded on Jun 28, 2019. It took 132 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-27.4%Jan 11, 2018360Jun 28, 2019132Jan 13, 2020492
-26.86%Sep 27, 2021157May 17, 2022
-23.77%Jan 6, 201686May 13, 201649Jul 22, 2016135
-22.86%Mar 28, 201795Aug 11, 201795Dec 29, 2017190
-18.53%Apr 28, 202022May 29, 202046Aug 3, 202068

Volatility Chart

The current Alkem Laboratories Limited volatility is 6.63%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%December2023FebruaryMarchAprilMay
6.63%
4.01%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)